Buy Metocin 4-HO-MET 21 MG Blister

Product Overview

Metocin 4-HO-MET 21 mg Blister provides 4-hydroxy-N-methyl-N-ethyltryptamine (4‑HO‑MET, Metocin) as a unit-dose solid research chemical formatted for consistent handling in controlled laboratory workflows. The blister presentation helps laboratories manage individual pellets as discrete research units while maintaining product integrity and traceability from storage through internal use.

4‑HO‑MET is a synthetic indole-based tryptamine and is classified in forensic and technical literature as a novel tryptamine analogue structurally related to psilocin and other 4‑hydroxy tryptamines. In this product, the compound is supplied as a brandless research chemical at ≥98% purity, specifically for non-clinical applications such as analytical method development, reference standard preparation, and structural or comparative chemistry. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Chemical Identity & Classification

4-HO-MET (4-hydroxy-N-methyl-N-ethyltryptamine) is a synthetic indole alkaloid of the tryptamine class. Tryptamines share a core bicyclic indole heterocycle linked via an ethyl side chain to a terminal amine, and 4‑HO‑MET is specifically substituted with a hydroxyl group at the 4‑position and an N‑methyl‑N‑ethyl substitution at the terminal amine.

Key identifiers include:

• Preferred chemical name: 4-hydroxy-N-methyl-N-ethyltryptamine

• Common names: 4-HO-MET, Metocin, Methylcybin, 4-hydroxy MET, 4-OH-MET

• CAS number: 77872-41-4

• Molecular formula: C13H18N2O

• Molecular weight: approx. 218.3 g/mol

• IUPAC-style name: 3-[2-(ethylmethylamino)ethyl]-1H-indol-4-ol

Classification in research and forensic contexts:

• Synthetic 4‑hydroxy tryptamine analogue of psilocin (4‑HO‑DMT) and 4‑AcO‑MET.

• Novel tryptamine analogue used as an analytical and forensic reference compound.

Chemical & Physical Characteristics

Technical briefings and forensic reports describe 4‑HO‑MET as a solid organic compound, with base material reported as a brown or off‑white solid, while properly refined salts present as white to light beige powders or crystals. 4‑HO‑MET is reported to occur as hydrochloride or fumarate salts in typical research-market samples, which influences appearance and handling properties.

The compound’s core structure (indole ring with a 4‑hydroxy substituent and an N‑methyl‑N‑ethyl side chain) defines its classification as a 4‑hydroxy homolog of 4‑AcO‑MET and an N‑ethyl homolog of psilocin. Reference data list the molecular formula C13H18N2O and a molecular weight of approximately 218.3 g/mol, consistent across chemical databases and forensic reports. Supplier information for 4‑HO‑MET indicates solubility in polar organic solvents such as DMF and DMSO at relatively high concentrations, with lower solubility in aqueous media unless mixed solvent systems are used.

Blistered pellet formulations, as used in Metocin 4‑HO‑MET 21 mg Blister, are engineered to provide consistent physical units and to protect each pellet from abrasion and environmental exposure until removed for research use. Any lot-specific information regarding color, crystalline habit, or melting behavior is typically detailed on the batch certificate of analysis.

Purity & Analytical Verification

Metocin 4-HO-MET 21 mg Blister is specified at ≥98% purity, aligning with expectations for high-grade research chemicals and reference materials in the tryptamine class. Forensic and analytical reports on 4‑HO‑MET indicate that well-characterized reference materials are used as comparison standards in LC‑MS and GC‑MS workflows, underscoring the importance of high assay values and defined impurity profiles.

Identity and purity confirmation typically involve multiple complementary techniques, including:

• Chromatographic methods such as LC‑MS or HPLC for assay and impurity profiling.

• Mass spectrometry for molecular-ion, fragment, and exact-mass confirmation.

• NMR and IR spectroscopy for structural verification where applicable.​

Safety data sheets and technical product pages explicitly state that 4‑HO‑MET/Metocin is supplied for research use only and not for human use, reflecting its role as a lab reagent rather than a formulated drug. Batch-specific COAs generally summarize assay values, key analytical parameters, and relevant test methods for each lot.

Quality Control & Batch Integrity

Forensic and reference-lab documentation shows that 4‑HO‑MET standards are prepared and characterized under controlled conditions, with specific batch numbers linked to reference spectra and chromatographic data. In commercial research supply, each production lot is assigned a unique identifier to ensure full traceability from synthesis through pellet manufacture and blister packaging.

Quality control programs for 4‑HO‑MET reference materials commonly include:

• Verification of chemical identity against a trusted reference standard.

• Purity testing and impurity characterization within defined acceptance limits.

• Checks on appearance, pellet integrity, and packaging/label accuracy before release.

Documented QC and traceability allow laboratories to maintain audit-ready records and to reproduce analytical work with consistent input material across different projects and time points.

Safety, Handling & Laboratory Precautions

4‑HO‑MET is described in forensic and harm-monitoring documents as a psychoactive synthetic tryptamine, which reinforces the need for careful handling even in non-clinical environments. Product safety documentation states that 4‑HO‑MET/Metocin is for research use only and not for human use, and that it should be handled only by trained personnel in appropriately equipped laboratories.

Standard lab precautions include:

• Use of appropriate personal protective equipment (PPE) such as gloves, protective eyewear, and lab coats.

• Working in well-ventilated areas or under suitable engineering controls when manipulating powders or pellets.​

• Avoiding generation of dust or aerosols and preventing uncontrolled release into the workspace or environment.​

Users should consult the substance-specific safety data sheet for hazard classification, recommended exposure controls, spill-management procedures, and waste-disposal guidelines, and must follow all internal safety policies and regulatory requirements. No guidance is provided or implied regarding dosing, administration, or any clinical or personal use.

Packaging, Labeling & Storage

Metocin 4-HO-MET 21 mg Blister is supplied in sealed blister strips containing individual pellets, enclosed in secondary protective packaging suitable for research chemical logistics. Blister formats provide tamper-evident sealing at the unit level and help protect each pellet from moisture, oxygen, and mechanical abrasion until removed for laboratory use.

Labels and documentation typically include:

• Product designation (Metocin 4‑HO‑MET).

• CAS number (77872‑41‑4), molecular formula, and batch/lot number.

• Core hazard and precautionary statements and a “research use only” notice.

Technical data sheets recommend storage at low temperature (e.g., −20 °C) in a dry, light-protected environment to maintain stability. The blister should be kept in its original packaging until use, and access should be restricted to authorized laboratory staff.

Intended Research Use & Market Positioning

4‑HO‑MET is identified in the literature as a novel tryptamine analogue and structural homolog of psilocin, which has led to its use as a target analyte and reference compound in forensic, toxicological, and analytical chemistry contexts. Metocin 4-HO-MET 21 mg Blister is therefore positioned strictly as a research chemical for:

• Analytical method development and validation (e.g., LC‑MS/GC‑MS detection in biological or seized samples).

• Structural and comparative studies within the 4‑hydroxy tryptamine family.

• Internal reference or system-suitability material in specialized laboratories.

The product is not developed, marketed, or suitable for human or veterinary use, and is not intended for clinical, diagnostic, therapeutic, or consumptive applications. Any discussion of psychoactive properties in open literature pertains to separate observational or clinical contexts, not to the intended use of this blistered research material.

Ordering, Availability & Fulfillment

Commercial listings for Metocin/4‑HO‑MET pellets explicitly state that the material is sold for research purposes only and is not intended for human use. Metocin 4-HO-MET 21 mg Blister is typically offered through specialized research-chemical channels to verified institutional and professional customers, with product pages highlighting purity (≥98%), unit content, and research-only classification.

Order documentation will usually reference:

• Product name and core chemical identity (4‑HO‑MET).

• CAS number and lot/batch information for traceability.

• Explicit “research use only” wording to support internal compliance.

Shipments are prepared in robust, discreet outer packaging suitable for courier transport, and many suppliers provide tracked shipping and basic documentation support (e.g., COA, SDS) upon request.

Legal & Regulatory Disclaimer

This product is supplied strictly as a research chemical for use in laboratory environments by qualified professionals operating under appropriate institutional and regulatory oversight. It is not manufactured, approved, or intended for human or veterinary use and must not be used for clinical, diagnostic, therapeutic, or consumptive applications under any circumstances.

Responsibility for compliance with all applicable local, national, and international laws—including any scheduling, licensing, import/export, and controlled-substance regulations relating to 4‑hydroxy-N‑methyl‑N‑ethyltryptamine (4‑HO‑MET, Metocin)—rests solely with the purchaser and end user. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.